Sixty Degree Capital
Sixty Degree Capital is a VC firm investing in technology and healthcare innovation.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Sixty Degree Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
3,380,296Website Global Rank
4,349Website Monthly Traffic
Twitter Followers
Description
Sixty Degree Capital is a North American VC that invests in companies creating meaningful change in their industries, across sectors (software, digital infrastructure, healthcare, biotech) and across stages (as early as Series A, as late as pre-IPO). The firm has a global investment mandate, but currently focuses on the US market.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2020 | Veem | Series C | - |
| 5/2021 | Tact.ai | Series D | - |
| 11/2021 | Lime | Convertible Note | 0 |
| 11/2022 | Bionaut Labs | Series B | 0 |
| 2/2022 | Macrometa | Convertible Note | - |
| 6/2019 | Northern Biologics Inc. | Venture Round | 7.3M |
| 7/2021 | TransThera Biosciences | Series D | 100M |
| 3/2022 | RefleXion Medical | Venture Round | 0 |
| 1/2020 | Miovision | Series D | 0 |
| 1/2022 | Radius Agent | Series A | - |
| 10/2022 | DataGrail | Series C | 45M |
| 11/2021 | GrubMarket | Series E | 0 |
| 11/2021 | Bionaut Labs | Series B | - |
| 1/2019 | Turnstone Biologics | Series C | - |
| 7/2022 | Inspirna, Inc.(formerly Rgenix, Inc.) | Series D | 0 |
| 4/2021 | Antios Therapeutics | Series B | 0 |
| 1/2022 | Everly Health | Series F | - |
| 5/2019 | Schrödinger | Series E | 25M |
| 10/2020 | GrubMarket | Series D | 0 |
| 11/2018 | Antios Therapeutics | Series A | 0 |
| 11/2021 | Antios Therapeutics | Series B | 0 |
| 9/2020 | Libra Therapeutics | Series A | 29M |
| 8/2021 | T-knife | Series B | 110M |
| 9/2020 | Monte Rosa Therapeutics | Series B | 0 |
| 1/2023 | NextPoint Therapeutics | Series B | 0 |
| 4/2021 | Clearcover | Series D | 200M |
| 1/2022 | Korro Bio | Series B | 0 |
| 3/2021 | Monte Rosa Therapeutics | Series C | 0 |
| 7/2021 | Turnstone Biologics | Series D | 0 |
| 10/2021 | CinCor Pharma | Series B | 0 |
| 7/2022 | Inspirna, Inc.(formerly Rgenix, Inc.) | Series D | 0 |
| 3/2022 | RefleXion Medical | Venture Round | 0 |
| 2/2022 | Macrometa | Convertible Note | - |
| 1/2022 | Everly Health | Series F | - |
| 1/2022 | Radius Agent | Series A | - |
| 1/2022 | Korro Bio | Series B | 0 |
| 11/2021 | GrubMarket | Series E | 0 |
| 11/2021 | Bionaut Labs | Series B | - |
| 11/2021 | Lime | Convertible Note | 0 |
| 11/2021 | Antios Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
